Nyumbani › Colitis ya Ulcerative
Majaribio ya kliniki ya Colitis ya Ulcerative yanayovutia washiriki nchini Marekani
Masomo 79 ya Colitis ya Ulcerative yanavutia washiriki katika vituo vya Marekani nzima.
Miji yenye masomo mengi
- New York City, NYUtafiti 23
- Orlando, FLUtafiti 22
- Miami, FLUtafiti 21
- Houston, TXUtafiti 17
- San Antonio, TXUtafiti 16
- Tacoma, WAUtafiti 15
- Chicago, ILUtafiti 15
- San Diego, CAUtafiti 15
- Tyler, TXUtafiti 14
- Colorado Springs, COUtafiti 14
- Los Angeles, CAUtafiti 13
- St. Louis, MOUtafiti 13
- Washington, DCUtafiti 12
- Boston, MAUtafiti 11
- Cincinnati, OHUtafiti 11
- Providence, RIUtafiti 11
- Louisville, KYUtafiti 10
- Parma, OHUtafiti 10
- Lewisville, TXUtafiti 10
- Durham, NCUtafiti 10
- Lubbock, TXUtafiti 9
- Tampa, FLUtafiti 9
- Evanston, ILUtafiti 9
- Atlanta, GAUtafiti 9
- Baltimore, MDUtafiti 8
- Mountain View, CAUtafiti 8
- Round Rock, TXUtafiti 8
- Garland, TXUtafiti 8
- Memphis, TNUtafiti 8
- Scottsdale, AZUtafiti 8
- Metairie, LAUtafiti 8
- Dallas, TXUtafiti 8
- Cleveland, OHUtafiti 8
- Seattle, WAUtafiti 8
- Waukegan, ILUtafiti 7
- Pittsburgh, PAUtafiti 7
- Fort Worth, TXUtafiti 7
- Charlotte, NCUtafiti 7
- Anaheim, CAUtafiti 7
- Wyoming, MIUtafiti 7
Kwa jimbo
- AlabamaUtafiti 7
- ArizonaUtafiti 19
- ArkansasUtafiti 4
- CaliforniaUtafiti 39
- ColoradoUtafiti 17
- ConnecticutUtafiti 11
- FloridaUtafiti 31
- GeorgiaUtafiti 14
- IdahoUtafiti 4
- IllinoisUtafiti 24
- IndianaUtafiti 10
- KansasUtafiti 10
- KentuckyUtafiti 13
- LouisianaUtafiti 15
- MarylandUtafiti 13
- MassachusettsUtafiti 16
- MichiganUtafiti 17
- MinnesotaUtafiti 8
- MississippiUtafiti 6
- MissouriUtafiti 16
- NevadaUtafiti 6
- New HampshireUtafiti 5
- New JerseyUtafiti 7
- New YorkUtafiti 30
- North CarolinaUtafiti 23
- OhioUtafiti 26
- OklahomaUtafiti 4
- OregonUtafiti 5
- PennsylvaniaUtafiti 12
- Rhode IslandUtafiti 11
- South CarolinaUtafiti 12
- South DakotaUtafiti 4
- TennesseeUtafiti 12
- TexasUtafiti 33
- UtahUtafiti 7
- VirginiaUtafiti 14
- WashingtonUtafiti 22
- Wilaya ya ColumbiaUtafiti 3
- WisconsinUtafiti 4
Masomo yaliyosasishwa hivi karibuni
Maandishi rasmi ya utafiti (Kiingereza)
Longitudinal Immunophenotyping of Patients With Inflammatory Bowel Disease
InaajiriUtafiti wa uchunguzi
Umri 18 hadi 85 · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT07619547Aquamin® for Prevention of Ulcerative Colitis J-Pouch-associate Intestinal Inflammation
InaajiriHatua 2
Umri 18 hadi 80 · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT07501078Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
InaajiriHatua 3
Umri wote · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT06651281Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
InaajiriHatua 2
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT07697456A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
InaajiriHatua 4
Umri 18 hadi 80 · Jinsia zote · Imesasishwa 30 Sep 2026 · NCT06581328A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
InaajiriHatua 3
Umri 2 hadi 17 · Jinsia zote · Imesasishwa 30 Sep 2026 · NCT07071519Confirmatory Clinical Study in Active Ulcerative Colitis
InaajiriHatua 2
Umri 16 na zaidi · Jinsia zote · Imesasishwa 30 Sep 2026 · NCT07296315A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
InaajiriHatua 2
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 30 Sep 2026 · NCT06598943Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
InaajiriHatua 1/2Wajitolea wenye afya wanakaribishwa
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 29 Sep 2026 · NCT06619990A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
InaajiriHatua 2
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 29 Sep 2026 · NCT07012395A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
InaajiriHatua 2
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 29 Sep 2026 · NCT07845487A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)
InaajiriHatua 2
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 28 Sep 2026 · NCT07463183A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 28 Sep 2026 · NCT06979336Immune Regulation in Ulcerative Colitis or Crohn s Disease
InaajiriUtafiti wa uchunguziWajitolea wenye afya wanakaribishwa
1 Day – 75 Years · Jinsia zote · Imesasishwa 28 Sep 2026 · NCT00001184A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
InaajiriHatua 3
Umri 12 na zaidi · Jinsia zote · Imesasishwa 25 Sep 2026 · NCT07196748A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
InaajiriHatua 3
Umri 3 na zaidi · Jinsia zote · Imesasishwa 25 Sep 2026 · NCT06663332A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
InaajiriHatua 2/3
Umri 2 hadi 17 · Jinsia zote · Imesasishwa 24 Sep 2026 · NCT05076175Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
InaajiriHatua 3
Umri 18 hadi 70 · Jinsia zote · Imesasishwa 24 Sep 2026 · NCT06937086Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 23 Sep 2026 · NCT03816345LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
InaajiriHatua 2
Umri 18 hadi 80 · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07186101A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
InaajiriHatua 2
Umri 18 hadi 80 · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07483073A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
InaajiriHatua 3
Umri 2 hadi 19 · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT04844606LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
InaajiriHatua 2
Umri 18 hadi 80 · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07415044A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
InaajiriHatua 4
Umri 18 hadi 65 · Jinsia zote · Imesasishwa 21 Sep 2026 · NCT06095128Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)
InaajiriHatua 2
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 21 Sep 2026 · NCT07513181Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.